Compare Medtronic PLC (MDT) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Zillow Group Inc Class A — how do they compare? Medtronic PLC trades at $82.45 (market cap $106.61B), while Zillow Group Inc Class A trades at $31.66 (market cap $7.54B). The key difference: Medtronic PLC is far larger — about 14.1× Zillow Group Inc Class A's market cap, and Medtronic PLC pays a 3.46% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.
| MDT | ZG | |
|---|---|---|
Market Cap | $106.61B | $7.54B |
Sector | Health | Media |
52-Week High | $105.35 | $86.76 |
52-Week Low | $73.75 | $29.14 |
Enterprise Value | $125.36B | $7.19B |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Zillow Group (ZG) trades at $32.84, down 2.58% on the day, amid a bearish technical signal and ongoing securities class action lawsuits. The company reported revenue of $2.58B in 2025 with a net income of $23M, marking a return to profitability after losses in prior years. Analyst consensus is a Buy with a $57.80 price target, but recent news highlights legal risks from alleged anticompetitive practices.
The outlook is mixed: strong fundamentals with improving margins and revenue growth support upside potential, but legal overhangs and bearish technicals pose near-term risks. Investors should weigh the high P/E ratio of 134.8 against earnings beats and analyst optimism for long-term recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
